SCHEMBL6022003

SCHEMBL6022003

CCN(CC)C(=O)[C@H]1CCCN(Cc2ccc(C(=O)CNCCOC(=O)N(c3ccccc3-c3ccccc3)N3CC[CH]CC3)cc2)C1

nearest known ligand 0.50

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 6/20 0.50
POLB P06746 1/20 0.45
HTT P42858 2/20 0.44
ATM Q13315 1/20 0.42
L3MBTL1 Q9Y468 1/20 0.42
RAB9A P51151 1/20 0.42
ALDH1A1 P00352 4/20 0.41
MAPT P10636 2/20 0.41
AKT1 P31749 1/20 0.40
BCHE P06276 2/20 0.39
PKM P14618 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
HSD17B10 Q99714 1/20 0.38
ACHE P22303 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2638612 0.87 KDM4E (0.50) KDM4EPOLBHTTATML3MBTL1
SCHEMBL2639463 0.83 KDM4E (0.46) KDM4EPOLBHTTATML3MBTL1
SCHEMBL5501520 0.83 CHRM2 (0.43) KDM4ERAB9AALDH1A1AKT1BCHE
SCHEMBL4691194 0.82 DRD4 (0.38) KDM4ERAB9AALDH1A1MAPTAKT1
SCHEMBL5412081 0.81 CD274 (0.44) L3MBTL1RAB9AAKT1SMN1; SMN2
SCHEMBL4694768 0.81 HDAC1 (0.36) BCHESMN1; SMN2ACHE
SCHEMBL4695736 0.81 ALDH1A1 (0.40) ALDH1A1
SCHEMBL4695744 0.81 HDAC1 (0.37) KDM4EPOLBRAB9AALDH1A1MAPT
SCHEMBL4695511 0.80 PDCD1 (0.34) HTTSMN1; SMN2
SCHEMBL4694755 0.79 OPRK1 (0.32) KDM4ERAB9AALDH1A1PKMSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1723114-A1 BIPHENYL COMPOUNDS USEFUL AS MUSCARINIC RECEPTOR ANTAGONISTS Theravance, Inc. (US) 2006-11-22 EP disclosed
WO-2005087738-A1 BIPHENYL COMPOUNDS USEFUL AS MUSCARINIC RECEPTOR ANTAGONISTS THERAVANCE, INC. (US) 2005-09-22 WO disclosed